Medically reviewed by Marla Anderson, MD Multiple myeloma is a type of blood cancer that forms in plasma cells, white blood ...
The FDA has granted orphan drug designation to the oral agent OPN-6602 for the treatment of patients with relapsed or ...
Offering state-of-the-art genetic testing to patients with the blood cancer myeloma would help doctors spot those with the most aggressive forms of the disease so that their cancer can be targeted ...
The PDUFA action date for an FDA decision for linvoseltamab to treat adult patients with relapsed/refractory multiple myeloma ...
The FDA accepted Regeneron’s BLA resubmission for linvoseltamab in relapsed or refractory multiple myeloma, with a decision ...
Flight Sergeant Zach Stubbings, a flying instructor who trained Prince William when he was based at RAF Valley in Anglesey ...
A 51-year-old man with multiple myeloma (diagnosed in December 2019 ... disappearance of any soft-tissue plasmacytomas, less than 5% plasma cells in bone marrow, normal free light-chain ratio ...
To Measure is to Predict; Characterization of Response to Therapy in Plasma Cell Disorders ...
Acceptance follows resolution of third-party fill/finish manufacturing issuesFDA decision expected by July 10, 2025 TARRYTOWN, N.Y., Feb. 11, ...
Billionaire hotelier Ong Beng Seng has been diagnosed with cancer. The 79-year-old has been undergoing chemotherapy for ...
CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on innovative CAR T-cell therapies for the treatment of hematologic malignancies and solid tumors, announces that the ...